Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-24-052485

Chief Product Officer acquired 41,408 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Besch Doug Chief Product Officer 2024-12-23 Grant or award +41,408 52,991 D
Derivatives
Besch Doug Chief Product Officer 2024-12-23 Grant or award · Stock Option +77,742 77,742 D
Loading xslF345X05/wk-form4_1735326482.xml…